Abiopharma

Two New Publications from the Independent THERMAC Trial Featuring IceCures ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Star Equity Holdings, Inc. RPO Subsidiary Rebrands to Hudson Talent Solutions

CorMedix Announces Strategic Minority Investment in Talphera

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025

Guardant Health, Inc. - Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States